Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Weizmann Institute of Science, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Weizmann Institute of Science, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Weizmann Institute of Science, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Weizmann Institute of Science, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Weizmann Institute of Science, Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| Weizmann Institute of Science, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Weizmann Institute of Science, Pharmaceuticals &Healthcare, Deal Details | 12 | 19 |
| Partnerships | 12 | 1 |
| Galmed Pharma Enters into Research Agreement with Yeda Research and Development | 12 | 1 |
| Sun Pharma Enters into Research Agreement with Weizmann Institute of Science and Health Research Institute of Santiago de Compostela | 13 | 1 |
| XL-protein Enters into Collaboration Agreement with Yeda Research | 14 | 1 |
| Rosetta Genomics Enters into Co-Development Agreement with Weizmann Institute of Science | 15 | 1 |
| Immune Pharma Enters Into Co-Development Agreement With Yeda Research | 16 | 1 |
| Abbott Labs Enters Into Co-Development Agreement With Yeda Research | 17 | 1 |
| Licensing Agreements | 18 | 1 |
| Merck Enters into Licensing Agreement with Weizmann Institute of Science | 18 | 1 |
| Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development | 19 | 1 |
| TxCell Exercises Option for Licensing Agreement with Yeda Research and Development | 20 | 1 |
| Tikcro Technologies Emends its Research and Licensing Agreement with Yeda Research and Development | 21 | 1 |
| Soligenix Enters into Licensing Agreement with New York University and Yeda Research and Development | 22 | 1 |
| PsychoGenics Enters into Licensing Agreement with Yeda Research and Development | 23 | 1 |
| XTL Biopharma Amends Licensing Agreement with Yeda Research for hCDR1 | 24 | 1 |
| miCure Therapeutics Enters into Licensing Agreement with Yeda Research | 25 | 1 |
| PROLOR Biotech Enters Into Licensing Agreement With Yeda Research | 26 | 2 |
| XTL Biopharma Enters into Licensing Agreement with Yeda Research and Development | 28 | 1 |
| Raptor Pharma Enters Into Licensing Agreement With Weizmann Institute And Niigata University | 29 | 2 |
| Weizmann Institute of Science - Key Competitors | 31 | 1 |
| Key Employees | 32 | 1 |
| Locations And Subsidiaries | 33 | 1 |
| Head Office | 33 | 1 |
| Other Locations &Subsidiaries | 33 | 1 |
| Appendix | 34 | 1 |
| Methodology | 34 | 1 |
| About GlobalData | 34 | 1 |
| Contact Us | 34 | 1 |
| Disclaimer | 34 | 1 |